Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026

Same author

Updates in the pharmacologic management of various Castleman disease subtypes: A comprehensive review.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Same author

Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Same author

Selecting optimal therapy for chronic neutrophilic leukemia: new prospects based on genetic and molecular makeup.

Expert opinion on pharmacotherapy·2025

Same author

Zanubrutinib‑Induced Symmetrical Soft Tissue Forearm Swelling in a Patient With Waldenström Macroglobulinemia.

Cureus·2025

Same author

Optimizing outcomes in chronic myelomonocytic leukemia: sequencing approved therapies and new prospects.

Expert opinion on pharmacotherapy·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Three-Dimensional Cell Culture of Adipose-Derived Stem Cells in a Hydrogel with Photobiomodulation Augmentation

Three-Dimensional Cell Culture of Adipose-Derived Stem Cells in a Hydrogel with Photobiomodulation Augmentation

Published on: April 5, 2024

Lasers, stem cells, and COPD.

Feng Lin¹, Steven F Josephs, Doru T Alexandrescu

¹Entest BioMedical, San Diego, CA, USA.

Journal of Translational Medicine

|February 18, 2010

Summary

This summary is machine-generated.

Low level laser (LLL) irradiation, a non-invasive therapy, shows potential in regenerative medicine. This "photoceutical" approach may enhance stem cell therapies by boosting growth factors, angiogenesis, and stem cell proliferation.

More Related Videos

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Published on: April 24, 2020

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Three-Dimensional Cell Culture of Adipose-Derived Stem Cells in a Hydrogel with Photobiomodulation Augmentation

Three-Dimensional Cell Culture of Adipose-Derived Stem Cells in a Hydrogel with Photobiomodulation Augmentation

Published on: April 5, 2024

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Published on: April 24, 2020

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Area of Science:

Regenerative Medicine
Biophotonics
Cell Biology

Background:

Low Level Laser (LLL) irradiation has a long history in treating tissue healing and inflammatory conditions.
The precise mechanisms of LLL irradiation are not fully understood, but its non-invasive and non-thermal nature makes it a promising area for research.
Novel therapeutic strategies are needed to augment existing stem cell-based treatments.

Purpose of the Study:

To explore the potential of LLL irradiation as a
photoceutical
intervention for enhancing stem cell therapies.
To discuss how LLL irradiation can modulate regenerative processes, including stem cell behavior and supporting microenvironments.

Main Methods:

Review of existing literature on LLL irradiation and stem cell interactions.
Discussion of LLL's effects on stem cell growth/chemoattractant factor production.
Analysis of LLL's impact on angiogenesis and direct stem cell proliferation.

Main Results:

LLL irradiation may enhance the production of stem cell growth and chemoattractant factors.
LLL irradiation can stimulate angiogenesis, crucial for tissue repair and regeneration.
LLL irradiation directly augments the proliferation of stem cells, increasing their numbers.

Conclusions:

LLL irradiation presents a promising
photoceutical
approach to enhance stem cell-based therapies.
Combining LLL irradiation with autologous and allogeneic stem cells could improve therapeutic outcomes.
Further research into LLL mechanisms is warranted to optimize its application in regenerative medicine.